Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes

By sjmartinez • May 7, 2025

Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei TH, Singal A, Hoteit MA, Park LS, Kaplan D, Lo Re V 3rd. Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes. Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70154. doi: 10.1002/pds.70154. PMID: 40328444.

Tags: Cholangiocarcinoma, Infectious Diseases, liver cancer, Outcomes, Publications, validation studies, Veterans Administration

Immune-epithelial-stromal networks define the cellular ecosystem of the small intestine in celiac disease

FitzPatrick MEB, Antanaviciute A, Dunstan M, Künnapuu K, Trzupek D, Provine NM, Dooley K, Zhang JY, Irwin SL, Garner LC, Pernes JI, Ferreira RC, Sasson[...]

Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States

Nambiar P, Liang T, Labo N, Hand J, Blumberg EA, Rana MM, Florman S, Haydel B, Morris MI, Schaenman J, Rodrigues MMS, Werbel WA, Bowring[...]

DNA methylation predicts infection risk in kidney transplant recipients

Hsu FM, Pickering H, Rubbi L, Thompson M, Reed EF, Pellegrini M, Schaenman JM. DNA methylation predicts infection risk in kidney transplant recipients. Life Sci[...]